CEO van Klotho Neurosciences neemt deel aan inaugurele conferentie en wetenschappelijk seminar
Klotho Neurosciences, Inc. (KLTO)
Company Research
Source: PR Newswire
NEW YORK, 9 september 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (NASDAQ: KLTO) ("Klotho" of "het bedrijf"), een biotechnologiebedrijf dat op Klotho gebaseerde therapeutica voor neurodegeneratieve aandoeningen ontwikkelt, kondigt aan dat CEO en voorzitter Dr. Joseph Sinkule de inaugurele Klotho Conferentie & Scientific Seminar zal bijwonen. Het evenement, de allereerste conferentie over de toekomst van op klotho gebaseerde therapieën en diagnostiek, gaat door in het UC-Irvine Beal Applied Innovation Center in Irvine, Calif. van 15 tot 16 september 2025.De twee belangrijkste wetenschappelijke adviseurs en uitvinders van het bedrijf, Dr. Miguel Chillon en Dr. Assumpcio Bosch, zullen hun onderzoek in Klotho-gentherapie voor de behandeling van ALS, Alzheimer en een lang leven presenteren.Tijdens de conferentie is Dr. Sinkule beschikbaar om investeerders en potentiële partners te ontmoeten. Geïnteresseerden kunnen contact opnemen via ir@klothoneuro.com. Over Klotho Neurosciences, Inc.
Show less
Read more
Impact Snapshot
Event Time:
KLTO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
KLTO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
KLTO alerts
High impacting Klotho Neurosciences, Inc. news events
Weekly update
A roundup of the hottest topics
KLTO
News
- Klotho Neurosciences Wins the 2025 BioTech Breakthrough 'Cell Therapy Innovation of the Year' AwardPR Newswire
- Klotho Neurosciences CEO to Attend Longevity Biotech 2025 in BostonPR Newswire
- Klotho Neurosciences Announces Expiration of Letter of Intent [Yahoo! Finance]Yahoo! Finance
- Klotho Neurosciences Announces Expiration of Letter of IntentPR Newswire
- Klotho to acquire Turn Biotechnologies' assets [Yahoo! Finance]Yahoo! Finance
KLTO
Sec Filings
- 12/5/25 - Form S-1
- 11/13/25 - Form 10-Q
- 11/6/25 - Form S-8
- KLTO's page on the SEC website